Financial results - NOVUS PHARMA DISTRIBUTION S.R.L.

Financial Summary - Novus Pharma Distribution S.r.l.
Unique identification code: 42071660
Registration number: J2020000013237
Nace: 4646
Sales - Ron
4.409
Net Profit - Ron
-1.366
Employees
Open Account
Company Novus Pharma Distribution S.r.l. with Fiscal Code 42071660 recorded a turnover of 2024 of 4.409, with a net profit of -1.366 and having an average number of employees of - . The company operates in the field of Comerţ cu ridicata al produselor farmaceutice și medicale having the NACE code 4646.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Novus Pharma Distribution S.r.l.

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR - - - - - 5.449 5.760 11.233 1.071 4.409
Total Income - EUR - - - - - 5.449 8.833 16.175 4.057 34.825
Total Expenses - EUR - - - - - 9.395 12.495 18.582 14.681 36.191
Gross Profit/Loss - EUR - - - - - -3.947 -3.662 -2.407 -10.624 -1.366
Net Profit/Loss - EUR - - - - - -4.098 -3.928 -2.737 -10.624 -1.366
Employees - - - - - 0 0 0 0 0
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 313.8%, from 1.071 euro in the year 2023, to 4.409 euro in 2024.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Novus Pharma Distribution S.r.l.

Rating financiar

Financial Rating -
NOVUS PHARMA DISTRIBUTION S.R.L.

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Novus Pharma Distribution S.r.l.

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Novus Pharma Distribution S.r.l.

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Novus Pharma Distribution S.r.l.

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Novus Pharma Distribution S.r.l. - CUI 42071660

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets - - - - - 3.383 842 30.973 29.768 3.412
Current Assets - - - - - 11.421 18.727 21.343 23.030 24.616
Inventories - - - - - 0 0 5 19 6
Receivables - - - - - 9.450 10.267 14.950 15.683 17.090
Cash - - - - - 1.971 8.460 6.388 7.329 7.520
Shareholders Funds - - - - - -4.017 -7.856 -10.617 -21.086 -22.334
Social Capital - - - - - 81 79 79 202 201
Debts - - - - - 19.061 27.425 62.986 73.884 50.362
Income in Advance - - - - - 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "4646 - 4646"
CAEN Financial Year 4619
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 24.616 euro in 2024 which includes Inventories of 6 euro, Receivables of 17.090 euro and cash availability of 7.520 euro.
The company's Equity was valued at -22.334 euro, while total Liabilities amounted to 50.362 euro. Equity decreased by -1.366 euro, from -21.086 euro in 2023, to -22.334 in 2024.

Risk Reports Prices

Reviews - Novus Pharma Distribution S.r.l.

Comments - Novus Pharma Distribution S.r.l.

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.